Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Influenza

  Free Subscription


Articles published in PLoS Biol

Retrieve available abstracts of 23 articles:
HTML format



Single Articles


    June 2025
  1. YIN X, Pu Y, Yuan S, Pache L, et al
    Global siRNA screen identifies human host factors critical for SARS-CoV-2 replication and late stages of infection.
    PLoS Biol. 2025;23:e3002738.
    PubMed     Abstract available


    April 2025
  2. GILBERT SC
    Priorities for rapid and cost-effective vaccines to improve outbreak responses.
    PLoS Biol. 2025;23:e3003114.
    PubMed     Abstract available


  3. KUBINSKI HC, Despres HW, Johnson BA, Schmidt MM, et al
    Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation.
    PLoS Biol. 2025;23:e3003115.
    PubMed     Abstract available


    January 2025
  4. MEARS HV, Young GR, Sanderson T, Harvey R, et al
    Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion.
    PLoS Biol. 2025;23:e3002982.
    PubMed     Abstract available


    December 2024
  5. KUCHARSKI AJ
    Controlling minor outbreaks is necessary to prepare for major pandemics.
    PLoS Biol. 2024;22:e3002945.
    PubMed     Abstract available


    November 2024
  6. DADONAITE B, Ahn JJ, Ort JT, Yu J, et al
    Deep mutational scanning of H5 hemagglutinin to inform influenza virus surveillance.
    PLoS Biol. 2024;22:e3002916.
    PubMed     Abstract available


  7. HAY JA, Zhu H, Jiang CQ, Kwok KO, et al
    Reconstructed influenza A/H3N2 infection histories reveal variation in incidence and antibody dynamics over the life course.
    PLoS Biol. 2024;22:e3002864.
    PubMed     Abstract available


    September 2024
  8. LE PEN J, Paniccia G, Kinast V, Moncada-Velez M, et al
    A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist.
    PLoS Biol. 2024;22:e3002767.
    PubMed     Abstract available


    March 2024
  9. BEKDASH R, Yoshida K, Nair MS, Qiu L, et al
    Developing inhibitory peptides against SARS-CoV-2 envelope protein.
    PLoS Biol. 2024;22:e3002522.
    PubMed     Abstract available


    January 2024
  10. RUSSELL TW, Townsley H, Abbott S, Hellewell J, et al
    Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants.
    PLoS Biol. 2024;22:e3002463.
    PubMed     Abstract available


    December 2023
  11. SIMMONS HC, Watanabe A, Oguin Iii TH, Van Itallie ES, et al
    A new class of antibodies that overcomes a steric barrier to cross-group neutralization of influenza viruses.
    PLoS Biol. 2023;21:e3002415.
    PubMed     Abstract available


    November 2023
  12. VALE-COSTA S, Etibor TA, Bras D, Sousa AL, et al
    ATG9A regulates the dissociation of recycling endosomes from microtubules to form liquid influenza A virus inclusions.
    PLoS Biol. 2023;21:e3002290.
    PubMed     Abstract available


  13. ZHU Z, Fan H, Fodor E
    Defining the minimal components of the influenza A virus replication machinery via an in vitro reconstitution system.
    PLoS Biol. 2023;21:e3002370.
    PubMed     Abstract available


  14. KALIMUDDIN S, Ooi EE
    Minding the "T"s beyond the "B"s: Shaping vaccines for future pandemics.
    PLoS Biol. 2023;21:e3002351.
    PubMed     Abstract available


  15. LYTRAS S, Wickenhagen A, Sugrue E, Stewart DG, et al
    Resurrection of 2'-5'-oligoadenylate synthetase 1 (OAS1) from the ancestor of modern horseshoe bats blocks SARS-CoV-2 replication.
    PLoS Biol. 2023;21:e3002398.
    PubMed     Abstract available


    August 2023
  16. LADNER JT, Sahl JW
    Towards a post-pandemic future for global pathogen genome sequencing.
    PLoS Biol. 2023;21:e3002225.
    PubMed     Abstract available


  17. LOBINSKA G, Pilpel Y, Nowak MA
    Evolutionary safety of lethal mutagenesis driven by antiviral treatment.
    PLoS Biol. 2023;21:e3002214.
    PubMed     Abstract available


  18. KRAFT TS, Seabright E, Alami S, Jenness SM, et al
    Metapopulation dynamics of SARS-CoV-2 transmission in a small-scale Amazonian society.
    PLoS Biol. 2023;21:e3002108.
    PubMed     Abstract available


    July 2023
  19. OLAJIDE OM, Osman MK, Robert J, Kessler S, et al
    Evolutionarily conserved amino acids in MHC-II mediate bat influenza A virus entry into human cells.
    PLoS Biol. 2023;21:e3002182.
    PubMed     Abstract available


    June 2023
  20. STRINE MS, Cai WL, Wei J, Alfajaro MM, et al
    DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner.
    PLoS Biol. 2023;21:e3002097.
    PubMed     Abstract available


  21. CHEN NFG, Chaguza C, Gagne L, Doucette M, et al
    Development of an amplicon-based sequencing approach in response to the global emergence of mpox.
    PLoS Biol. 2023;21:e3002151.
    PubMed     Abstract available


  22. TSU BV, Agarwal R, Gokhale NS, Kulsuptrakul J, et al
    Host-specific sensing of coronaviruses and picornaviruses by the CARD8 inflammasome.
    PLoS Biol. 2023;21:e3002144.
    PubMed     Abstract available


    May 2023
  23. EALES O, Haw D, Wang H, Atchison C, et al
    Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England.
    PLoS Biol. 2023;21:e3002118.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.